SCHEMBL4099723

SCHEMBL4099723

COc1ccc(NC(=O)C(=O)c2c(Cl)n(Cc3ccc(Cl)cc3)c3ccc(OC)cc23)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.54
KMT2A Q03164 3/20 0.53
MAPT P10636 3/20 0.53
MEN1 O00255 2/20 0.53
RGS12 O14924 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
PKM P14618 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
MAPK1 P28482 1/20 0.53
CYP2C19 P33261 1/20 0.53
GNAI1 P63096 1/20 0.53
PMP22 Q01453 1/20 0.53
HIF1A Q16665 1/20 0.53
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2991095 0.99 FAAH (0.55) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL4101935 0.96 FAAH (0.54) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL4378535 0.94 FAAH (0.52) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL3001895 0.94 PLA2G2A (0.53) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL4094533 0.93 FAAH (0.53) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL4088945 0.93 FAAH (0.52) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL4088958 0.93 FAAH (0.64) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL2169278 0.92 FAAH (0.58) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL2169190 0.91 MAPT (0.55) FAAHKMT2AMAPTMEN1RGS12
SCHEMBL2169523 0.91 FAAH (0.66) FAAHKMT2AMAPTMEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885KMT2A 2103/4885MAPT 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.